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This brief essay summarizes some personal thoughts on the NIH grant system.  The 
thoughts arise in part from my experience as a dissenter from scientific orthodoxy, and in 
part from my experience as a member of several workshops convened to assess and fix 
problems with the NIH and NSF grant systems. 
 
1.  Has the scientific enterprise gone awry? 
 
A half-century ago, breakthroughs were fairly common events.  They could be counted 
on to occur on an unpredictable but not infrequent basis.  Pioneering such breakthroughs 
were now-legendary figures such as Linus Pauling, Jonas Salk, Richard Feynman, James 
Watson, Francis Crick — heroic names familiar even to lay people. 
 
But things have changed.  While the past 30 years have brought a great outpouring of 
scientific results, breakthroughs are less common.  Modern equivalents of Pauling, Salk, 
and Watson-Crick are not easy to identify.  Can you name more than a handful of 
breakthroughs that have emerged during the past three decades?  I mean realized 
breakthroughs such as revelation of the biochemical nature of heredity or a vaccine to 
eradicate a ravaging affliction, not incipient breakthroughs whose realization always 
seems just around the corner. 
 
Considering the currently massive investment in science, why are there so few scientific 
breakthroughs?  Why is it that scientific heroes are now so scarce? 
 
Some argue that this settling down is all but inevitable.  After all, science today is far 
more complicated than it has been, often requiring teams of investigators and large 
groups to pursue effectively.  Others argue that there is simply not much more to be 
discovered — that the breakthroughs have had their heyday and we need content 
ourselves with merely filling in the gaps.  Thus, breakthroughs might not be expected to 
occur on an everyday basis.  
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Perhaps some of this is true — but a significant role may also be played by another 
factor: the growing aversion to risk taking.  Although funding agencies have much to be 
proud of for past achievements, it is broadly perceived that they have become less agile in 
dealing with proposals that dissent from orthodoxy.  Challengers of the status quo rarely 
succeed in today’s scientific climate.  Hence, the approaches most apt to generate 
conceptual breakthroughs are frequently throttled before they can emerge from the 
scientific womb. 
 
The funding agencies are aware of this problem.  Both the NSF and the NIH have held 
recent workshops to deal with the issue, and some measures have been taken over and 
above existing remedial programs.  The term “high risk” now permeates NIH review 
guidelines.  The NIH has established five to ten “Pioneer Awards” each year to 
encourage novel approaches.  And R21 “high risk” grants have been available from many 
Institutes for some time. 
 
While these responses acknowledge the problem, it is broadly felt that they are nominal.  
Few dissenters from orthodoxy report any success with the R21 system, and even some 
NIH administrators admit that these grants do not solve the problem. Admonishing 
reviewers to be “less conservative” comes with no guarantee that they will be.  The 
Pioneer Awards were given last year to an impressive cohort, but these were not 
challengers of prevailing orthodoxy; recipients are well-funded mainstream scientists 
(~$1M mean annual amount), who have enjoyed considerable success within the system.  
Also, the number of awards, nine last year, makes little dent in the surface of an 
otherwise tough, pervasive and serious problem.  Thus, effective action has yet to be 
taken. 
 
I am not alone in this view.  A recent, highly praised book by Donald Braben, entitled 
Pioneering Research: A Risk Worth Taking, concurs.  Braben argues that limiting the 
ability of scientists to dissent from orthodoxy heralds a line of consequences leading 
ultimately to societal doom.  Only a radical departure from the highly bureaucratic, top-
down-managed approach to science, he argues, will solve the problem.  In the absence of 
such a departure, progress will remain incremental, despite a vast pool of talent and an 
abundant pool of monetary resources.  Freedom to dissent is essential. 
 
Thus, the scientific enterprise appears to have gone at least somewhat astray.  It has for 
sure generated a massive number of hugely productive enterprises whose outpouring of 
results seems to come ever closer to generating the hoped-for conceptual breakthroughs.  
But those breakthroughs rarely materialize.  Always, it seems they are just around the 
corner.  A reason for this mixed track record is that the very approaches that could lead to 
the desired breakthroughs — those that challenge the current line of thinking with fresh 
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2.  Source of the Problem 
 
If this situation seems as antithetical to science to you as it does to me, how could it have 
arisen?  I consider two sources: the scientific culture and the grant system. 
 
A.  The scientific culture 
 
Scientists since the time of the ancient Greeks have been dedicated to the pursuit of truth, 
and the same dedication applies today.  We want to find out how the world really works.  
On the other hand, in response to societal demands for finding cures to diseases and 
developing technologies to compete effectively in a world growing ever more complex, 
science has grown from the small cottage industry it once was, into a big business.  It 
consumes money and generates products.  Whether the business-like culture spawned by 
this transformation has brought complicating features that might compromise the noble 
goal of science is an issue that needs to be considered. 
 
Formerly, science was a modest endeavor.   Principals were largely known to one 
another, and they enjoyed support either from a benefactor, or from having been born into 
a family of wealth.   Scientific pursuit was largely unfettered by the exigencies of 
everyday life, because it was practiced by a talented and fortunate few. 
 
Today, science has grown to a massive enterprise, not unlike a big business.  The 
business is supported by tax-paying investors, who channel their investments through 
organizations such as the NSF and NIH.  In return, the business generates useful 
products.  These products are mainly conceptual frameworks describing how the universe 
operates.  They are belief systems - theories and hypotheses emerging out of available 
evidence.  Thus, money is invested and belief systems are generated.   The presumption is 
that such belief systems will eventually be useful for advancing technologies, curing 
afflictions, accruing national prestige, etc. 
 
Investors are patient.  Especially with the promise of incipient breakthroughs, the public 
is remarkably willing to continue its investment, recollecting the incredible scientific and 
medical breakthroughs of the past and anticipating even more in the future.  At least for 
now, it is axiomatic that scientific and medical research will enjoy continuing (albeit 
fluctuating levels of) support.  Investors will not pull the plug. 
 
It is this implicit confidence that may be the first reason for the existing problem.  The 
scenario is akin to a business that does not need to compete.  Ordinary businesses must 
innovate to beat the competition, but the scientific business suffers little such concern, for 
so long as the promise of incipient medical breakthroughs continues to be as well 
advertised as it is now, the public will continue to invest. 
 
Safe and secure, the scientific endeavor presses on.  Truth seeking certainly remains high 
on its agenda — but who is checking to see what fresh and insightful truths have been 
uncovered?  Which investors will demand a list of last year’s conceptual breakthroughs?  
Such breakthroughs are anyway presumed to be beyond the investors’ ability to 
understand, so why even bother.  Scientists have become largely insulated from public 
scrutiny, hidden within the confines of the huge business complex that is today’s science.  
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Breakthroughs are welcome, but certainly not demanded or even expected.  Making 
progress is sufficient. 
 
To illustrate the point, consider the expectations implicit in the typical government-grant 
proposal.  Within the NIH system, applicants are obliged to project annual milestones: 
What will be accomplished by the end of year 01? Year 02?  Even, year 05.  Such 
requirements amount to implicit admission that no breakthroughs are to be anticipated, 
for any unexpected finding will immediately change the direction of the research and 
render earlier projections irrelevant.  Scientific society has institutionalized its 
expectation that even modest breakthroughs will not happen, and this expectation is 
passed onto its scientists. 
 
If not satisfying the expectations of its patrons, what then motivates today’s scientists?  Is 
it the pure, noble and unfettered goal of seeking truth, or do extraneous factors come into 
play? 
 
My take is that the most pressing motivational factor comes not from outside the system, 
but from within: the competition to survive.  To survive, all scientists need funding.  The 
pressure is especially acute when one’s salary is at risk, and it is also acute in larger 
laboratories, where long-term staff akin to family must be supported uninterruptedly.  
Host universities turn up the pressure further.  They count on the indirect costs that come 
with grants to help pay their bills, and remind you of this when promotion and tenure 
considerations come around.  Thus, obtaining funding has become not just a means of 
paying for the costs of experimentation, but a relentless pressure in a fiercely competitive 
arena, which rarely abates.  By no means has the motivation to seek for truth been 
abandoned; but Darwinian survival is an additional motivator of some significance.  
 
How does one ensure survival in so competitive an arena? 
 
Obviously, attention needs to be paid to those determining your fate, and high among 
those are your grant reviewers.  Impressing them is important.  Being productive, 
motivated, and highly professional at all times will go a long way.  But the peers 
reviewing your application are also your competitors, seeking to fortify their own 
positions, and proposals that threaten to undercut those positions are not likely to be 
embraced with great warmth.  So, one must be ever cautious.  The safest bet is to avoid 
even any hint of serious dissent from orthodoxy.  Most every scientist knows it. 
 
In short, the culture has deflected scientists from their singularly noble goal of pursuing 
truth and challenging orthodox thinking whenever truth-seeking warrants.  Just keep it 
safe, and get your funding.  We have evolved into a culture of obedience, bowing to the 
high priests of orthodoxy in order to secure our own positions. 
 
As you might imagine, this culture generates some unwelcome side effects.  Among them 
are the following: 
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1. Truth plays a subsidiary role: In determining which belief systems prevail, 
survival-related issues may play a dominant role.  Truth may not necessarily be 
the singular factor. 
 
2. Crowd Power.  Those on review boards have commanding power, which can be 
subject to group reinforcement.  “Yes, this unorthodox proposal contains brilliant 
ideas, but, unfortunately….”  Colleagues around the review table are relieved, for 
any threat to the prevailing belief system impacts them, too.  The reviewer is 
applauded for his/her critical insight, and the establishment is sustained. 
 
3. Narrowness. Science is broadly conceived as a growing tree of knowledge:  The 
trunk, limbs, and major branches are thought solid and well defined; it is only the 
most peripheral twigs that remain to be elaborated — and that is the task of 
today’s scientists.  Few seem to be paying attention to whether the foundational 
limbs are really solid.  We are all too narrowly preoccupied dealing with the 
explosion of information to step back from details to rethink the fundamentals.  
We have defaulted into becoming a culture of believers. 
 
4. Aggression toward interlopers. The inner voice repeats:  “My colleagues have 
bestowed ample funding upon me; they seem to think my ideas are all right.  
Therefore, probably my ideas are all right.  Ergo, challengers are likely to be 
cranks bent on making unnecessary trouble.”  Challengers are too often arrogantly 
ridiculed.  Even scientists unfamiliar with the challengers’ work seem to take 
pleasure in demeaning it — many colleagues report this experience. 
 
5. Misplaced values.  With facts growing at an exponential rate, the growing density 
of peripheral twigs seems more and more to obscure the core paradigms.  From 
the outside, science looks like a thicket of complexity.  The notion of complexity 
is reinforced by the culture: grant programs provide ample support for large-scale 
computer models thought to be necessary to make sense out of the seemingly 
impenetrable minutiae.  But, what happened to Occam’s Razor?  The time-
honored approach of replacing complicated belief systems with simpler belief 
systems that explain more facts, has given way to a resignation that science is too 
complicated for any one person to comprehend in its entirety.  A sense of futility 
pervades — a sense that formidable problems can no longer be solved through 
bold approaches and fresh ideas. 
 
In sum, the culture of science is beset with a number of problems.  It has produced 
scientists whose drive to survive can sometimes overshadow their drive to pursue 
fundamental advances.  It accepts growing complexity as a given, and thereby offers 
limited incentive for scientists to find simplifying truths; those few scientists reckless 
enough to stray onto paths less traveled are marginalized by the majority of scientists, 
who are deeply and unquestioningly acculturated in their fields’ orthodoxy.  Dwelling 
within this orthodoxy, by contrast, promotes ample rewards.  Understandably, this is a 
culture that is not likely to produce much in the way of breakthrough science. 
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B. The Grant System – Perpetuator of Orthodoxy 
Shortly after the government-grant systems were created a half-century ago, Thomas 
Kuhn published his now-classic book entitled “The Structure of Scientific Revolutions,” 
arguing that science advances less by accretion of knowledge than by a series of scientific 
revolutions.  These revolutions, as we well know, were referred to as “paradigm shifts.”  
Often, normal science is completely overthrown by the work of some creative scientist 
who comes upon a finding so completely out of accord with the prevailing view that the 
latter becomes untenable.  Such paradigm shifts, Kuhn argues and many though not all 
scientists agree, make for the real advances in science.  
The NIH grant system was not designed to deal with proposals aimed at promulgating 
paradigm shifts.  Because it was created before Kuhn’s ideas became broadly known, the 
system was implicitly designed around the earlier common-sense principle of accretion of 
knowledge: Add flesh to the bones of the existing framework, and eventually the universe 
will be better understood.  As knowledge grows, so will understanding.  From such a 
perspective, peer review makes good sense and has produced much new knowledge  — 
for, who better than peers can judge whether a scientific proposal seems sound? 
For applications that dissent from orthodoxy, however, the merit of this system is less 
clear.  A fresh idea commonly challenges the status quo.  Sent to those for whom the 
status quo is a central belief system, the review outcome is more-or-less predictable:  too 
commonly, self-interest will block the application.  I do not demean the value of experts, 
or of knowledge over ignorance, only of the de facto power conferred on those who have 
risen to prominence within today’s establishment to dictate the direction of scientific 
inquiry.  It is all too easy for the establishment to deflect unpleasant challenges. 
Compare this grant-review system with a court of law.  Like the court, the scientific court 
is set up to adjudicate a matter — the fate of a grant application.  In a court of law, the 
jury is disinterested; it stands to gain or lose nothing whether the prevailing party is the 
plaintiff or the defendant.  In the scientific court a plaintiff makes the case against the 
defendant — who then turns around and acts as judge.  Imagine a court system in which a 
small auto company’s proposed innovation is to be judged by a representative of GM, 
who has veto power.  Situations of such happen, for sure – but is this a reasonable way to 
judge the merit of the plaintiff’s case? 
It is difficult to escape the conclusion that the peer review system virtually guarantees 
that the most far reaching of potential scientific advances will not be supported.  Genuine 
challenges of the status quo have little chance, and indeed, scientists broadly 
acknowledge that submission of proposals that challenge orthodox thinking borders on 
suicidal.  Any such forays are avoided like the plague. 
The take-home message?  Proper scientific citizens are those who dwell happily within 
the realms of orthodoxy.  The NIH-grant system promotes safe science, not breakthrough 
science. 
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In sum, the scientific endeavor is beset with problems originating both from the culture 
and from the grant system.  One reinforces the other.  The result is a proclivity to favor 
what is safe, and to shun what seems “risky.”  Einstein’s challenge of orthodoxy would 
probably have failed in today’s grant-review system, as would Galileo’s – not to mention 
Watson and Crick, whose coffins of failure would likely have been sealed by the absence 
of requisite background in nucleic acid biochemistry, and certainly by the absence of any 
preliminary data.  Could these chaps be worth the risk? 
It is the focus on safe science that in my estimate is responsible the dearth of conceptual 
breakthroughs and real (not promised) solutions to medical problems.  Left unchecked, 
the system guarantees that the future is not likely to be any more fruitful than the past. 
On the other hand, the issues cited above are not unique to the NIH; they pervade 
granting agencies worldwide.  Understanding their etiology may provide some helpful 
background through which remedial measures can be taken.  With well thought out 
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